Kambiz Yazdi
Stock Analyst at Jefferies
(1.97)
# 2,936
Out of 4,843 analysts
7
Total ratings
28.57%
Success rate
11.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTX Avalo Therapeutics | Initiates: Buy | $23 | $4.00 | +475.00% | 1 | Mar 25, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $19 | $13.04 | +45.71% | 2 | Mar 11, 2025 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $15 | $7.24 | +107.18% | 1 | Aug 28, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $5 | $0.88 | +469.35% | 1 | Apr 12, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $75 → $128 | $38.55 | +232.04% | 2 | Mar 26, 2024 |
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $23
Current: $4.00
Upside: +475.00%
Arcutis Biotherapeutics
Mar 11, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $13.04
Upside: +45.71%
EyePoint Pharmaceuticals
Aug 28, 2024
Initiates: Buy
Price Target: $15
Current: $7.24
Upside: +107.18%
PMV Pharmaceuticals
Apr 12, 2024
Initiates: Buy
Price Target: $5
Current: $0.88
Upside: +469.35%
Praxis Precision Medicines
Mar 26, 2024
Maintains: Buy
Price Target: $75 → $128
Current: $38.55
Upside: +232.04%